< Back to companies

Veravas is a leading innovator in clinical diagnostics focused on the early-stage detection of Alzheimer’s disease and other neurological conditions. The company’s proprietary VeraBIND™ technology transforms challenging sample types into measurable biomarkers, enabling earlier disease detection and the development of novel diagnostic tests. Its VeraBIND Tau assay is a first-in-class blood-based test that measures the pathological activity of hyperphosphorylated tau in blood samples of cognitively normal individuals or individuals experiencing cognitive impairment which may be used to aid in the diagnosis of Alzheimer's disease.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2017
Website
veravas.com/

Categories

Clinical DiagnosticsDiagnosticsAlzheimer(s) DiseaseScreening & Early Detection

Disease Areas

Technologies

BiomarkersDiagnostic PlatformsMolecular Diagnostics
Only accessible to MedStartr community members. Join now

What do you think of Veravas?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now